Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD
3.4K posts

Carol Wittlieb-Weber, MD
@wittlica
Pediatric Transplant Cardiologist @ChildrensPhila | Physician Well-being Lead @HeartCare4Kids |🏃♀️(26.2 x 12, 3:12:13) | Mom of 👦 🐶
Philadelphia, PA Katılım Ocak 2018
335 Takip Edilen288 Takipçiler
Carol Wittlieb-Weber, MD retweetledi

Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi

Dr. David Goldberg talks about medical therapy to make the healthy Fontan healthier, focusing on the potential role of PDE5 inhibitors. FUEL study (udenafil) failed to meet primary endpoint of improved VO2 max, follow-up study is ongoing in pts with reduced baseline VO2. #AHA25

English
Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi

Carol Wittlieb-Weber, MD retweetledi

Carol Wittlieb-Weber, MD retweetledi

Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi

We recently launched our Extracorporeal Life Support Fellowship, one of only a few worldwide, training pediatric intensivists in advanced life support like #ECMO. Hear from our first fellow, Dr. Hera Mahmood, on her transformative year: ms.spr.ly/6011srd2h #MedEd #PedsICU

English
Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi
Carol Wittlieb-Weber, MD retweetledi

Cardiac issues are a top cause of death in DMD - but are patients getting optimal treatment?
An ACTION study in Pediatric Cardiology found only 1 in 4 reached target doses, and 30% weren’t on all 3 recommended heart meds.
Read more here: bit.ly/44Dgm87. #MDMonday

English




















